SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BlackBerry Ltd. engages in the provision of intelligent security software and services. It operates through the following segments: QNX, Secure Communications, and Licensing. The QNX segment includes development of safe and reliable software for embedded systems across technology-driven industries. The Secure Communications segment delivers operational resiliency with a government-grade portfolio of secure, certified solutions for mobile fortification, critical communications and crisis management. The Licensing segment focuses on management and monetization of the firm's global patent portfolio. The company was founded by Michael Lazaridis, James Laurence Balsillie, and Douglas E. Fregin on March 7, 1984 and is headquartered in Waterloo, Canada.

BlackBerry Ltd

BlackBerry is trending as investors focus on its pivot into physical AI, robotics, and automotive software, with community discussions heavily centered on the potential of the QNX operating system and the Alloy Kore platform to drive future growth. Shareholders are actively tracking design wins and partnerships with major silicon and automotive players, viewing the company's foundational role in autonomous and safety-critical systems as a significant long-term value catalyst.

TRUMP is a politics-themed digital coin built on the Solana blockchain that uses the brand of Donald Trump to foster a community-driven ecosystem. As a community-focused asset, it is designed to bridge political support with web ownership, operating within the PolitiFi sector to blend political movements with decentralized finance tools. The project's main value proposition lies in its official ties to Donald Trump’s media and business brands, which allows it to provide unique physical utility such as invitations to gala dinners and meetings at Mar-a-Lago.  The token serves as the primary currency for the officially licensed Trump Billionaires Club mobile and web game, where it is used for in-game purchases and unlocking features. By leveraging the Solana blockchain, the project ensures that these in-game actions and token transfers remain fast and cost-effective. The ecosystem remains stable through a programmatic release schedule that introduces new tokens slowly to prevent supply shocks, alongside the use of specialized market makers to maintain consistent liquidity for traders.  Holders can also participate in liquidity sharing by providing their tokens to automated systems to facilitate trading for others, often earning rewards or prizes in return. Beyond digital utility, holding a specific amount of the token is a requirement for attending exclusive real-world events, including VIP parties at Mar-a-Lago. The project is managed by the Trump Meme Team and is linked with Trump Media, with an investor base that includes a wide range of retail buyers and large holders who utilize secure custody services for their assets.

Trump For President

Investors are actively debating allegations of a large-scale rug pull tied to the $TRUMP.X token, with discourse heavily polarized between community members defending the project as a speculative play and critics citing financial disclosures that suggest significant personal gains for the Trump family. The ongoing conversation centers on the contrast between the token's massive valuation decline and the substantial income reported by related crypto ventures.

Sigma Lithium Corp. engages in the producing of a lithium property. It focuses its project in Minas Gerais. The firm also plans to build a world-class commercial-scale lithium concentration plant. The company was founded on June 8, 2011 and is headquartered in Sao Paulo, Brazil.

Sigma Lithium Corporation

Sigma Lithium is seeing heightened community discussion as traders debate whether the stock is primed for a major breakout or remains vulnerable to volatility amid ongoing short-seller reports and regulatory speculation. Investors are closely monitoring upcoming production milestones, potential expansion plans, and the broader recovery of lithium spot prices as key catalysts for a move higher.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as the community rallies behind optimism for network upgrades, a massive governance vote approval, and speculative hopes for exchange re-listings and token burns. Despite volatile price action, sentiment remains polarized between long-term holders betting on an ecosystem revival and skeptics questioning the sustainability of the project's massive supply.

BlackBerry is seeing increased investor focus as the community highlights its pivotal role in the automotive and robotics sectors through its QNX operating system, which is increasingly integrated into next-gen edge AI hardware. Discussions are centered on the potential for new partnership announcements and the broader thesis that BlackBerry remains an undervalued foundation for physical AI as institutional interest in its software platforms continues to grow.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.

Cardano

Cardano is attracting significant community attention as traders debate whether current price levels represent a prime accumulation zone or a structural bear trap. While bulls point to recent network upgrades and whale accumulation as catalysts for a potential reversal, skeptics remain wary of the asset's long-term underperformance and ongoing market volatility.

Select Sector SPDR Trust (The) - State Street Financial Select Sector SPDR ETF

Financial Select Sector SPDR Fund

The financial sector is currently trending as investors monitor the impact of credit market conditions and interest rate uncertainty on major banks. Community discussions are centered on sector rotation trends, with many traders analyzing potential technical support levels and hedging strategies following recent volatility.

Arm Holdings Plc engages in the licensing, marketing, research, and development of microprocessors, systems IP, graphics processing units, physical IP and associated systems IP, software, and tools. It operates through the following geographical segments: United Kingdom, United States, and Other Countries. The company was founded on November 12, 1990 and is headquartered in Cambridge, the United Kingdom.

Arm Holdings plc. - ADR

Arm Holdings Plc.

Arm Holdings is facing intense volatility as investors debate whether the company's valuation can be justified by its AI-driven data center growth and AGI CPU pipeline. While the stock continues to attract aggressive short-term trading and community interest regarding technical support levels, many market participants are closely weighing long-term fundamentals against a cooling semiconductor sector.

Spdr Dow Jones Industrial Average ETF Trust - Spdr Dow Jones Industrial Average ETF Trust

The Dow Jones Industrial Average (DIA) is currently trending as markets exhibit heightened volatility, driven by uncertainty surrounding the Federal Reserve's upcoming interest rate decision and intensified geopolitical tensions in the Middle East. Community discussion is heavily focused on conflicting narratives regarding the sustainability of AI-sector capex spending, the impact of potential military escalations on global energy prices, and ongoing debates over whether current market price action signals a healthy rotation or the onset of a broader downturn.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is gaining traction as investors monitor institutional accumulation and prepare for a potential Q4 BLA submission for its prostate cancer therapy, CAN-2409. The community is focused on the company's progress with clinical catalysts and the upcoming BLA filing, with ongoing discussions surrounding institutional buying patterns and long-term valuation potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Johnson & Johnson is currently trending as analysts and investors favor the stock's defensive profile and long-term dividend reliability amid ongoing market rotation into high-quality healthcare names. Sentiment is further bolstered by positive pharmaceutical pipeline updates and recent analyst upgrades that highlight accelerating revenue potential from key growth drugs.

Halozyme's Q2 Earnings Beat Estimates, 2026 Outlook Raised, Stock Up

HALO's Q2 earnings and revenues surpass estimates, fueled by higher royalties and product sales. The company raises its 2026 outlook.

Johnson & Johnson (JNJ) Could Be a Great Choice

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Johnson & Johnson (JNJ) have what it takes? Let's find out.

ABBV Stock Dips 4% Despite Robust Q2: Buy the Dip or Stay Cautious?

ABBV falls after cutting its 2026 EPS outlook to reflect the Apogee deal, despite strong Q2 results, higher revenue guidance and growth from key medicines.

LLY Q2 Earnings Top, GLP-1 Drugs Fuel Growth, Sales Guidance Raised

LLY crushes Q2 earnings estimates and lifts its 2026 sales outlook as Mounjaro and Zepbound fuel strong revenue growth and newer drugs add momentum.

Should Investors Buy Boston Scientific Stock Despite Near-Term Risks?

Boston Scientific's cheaper valuation offers upside, but weaker guidance, share losses, higher debt and delayed catalysts favor patience.

Johnson & Johnson to Participate in the 2026 Wells Fargo Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will present at the 2026 Wells Fargo Healthcare Conference on Wednesday, September 9th, 2026. Management will participate in a Fireside Chat at 11:00 a.m. Eastern Time. A live audio webcast of the presentation will be accessible through Johnson & Johnsons Investor...

BAYRY Beats on Q2 Earnings, Crop Science Business Boosts Growth 

Bayer tops Q2 estimates as Crop Science and fast-growing drugs offset pressure from patent-expired brands, while reaffirming its 2026 outlook.

Johnson & Johnsons Executive Vice President Jennifer Taubert to Retire; Tom Cavanaugh Appointed EVP, Worldwide Chairman Innovative Medicine Effective September

Johnson & Johnson (NYSE: JNJ) today announced that Jennifer Taubert will retire from her position as Executive Vice President, Worldwide Chairman, Innovative Medicine following a distinguished career and over 21-year tenure at Johnson & Johnson. Under her leadership, the Companys Innovative...

4 Non-Tech Stocks to Grab as Dow Hits New Milestone Amid AI Sell-off

GS, JPM, TRV and JNJ stand out as Dow hits a new high amid an AI-driven tech sell-off, with these blue-chip stocks backed by strong earnings growth.

J&J's Strong Q2 Oncology Performance Fuels Future Growth Hopes

J&J's oncology business posted strong Q2 growth as Darzalex, Erleada and newer cancer drugs boosted sales and advanced its long-term ambitions.

$JNJ Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $2.27 down -0.87% YoY
• Reported revenue of $25.31B up 6.60% YoY
• Johnson & Johnson increased 2026 guidance with estimated reported sales of $101.1 billion at the midpoint and increased adjusted EPS guidance by $0.13 to $11.68 at the midpoint for fiscal 2026.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

JNJ Stock Advances After Hours On $5.5B Proposal To Resolve Talc Litigation

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Feed

News

Sentiment

Earnings

Fundamentals

Info

JNJJohnson & Johnson

Fundamentals

Connect Stocktwits to ChatGPT

Latest JNJ News